BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11155713)

  • 1. [Agammaglobulinemia as early B cell defects].
    Miyawaki T; Kanegane H; Futatani T
    Nihon Rinsho Meneki Gakkai Kaishi; 2000 Oct; 23(5):435-44. PubMed ID: 11155713
    [No Abstract]   [Full Text] [Related]  

  • 2. Agammaglobulinemia and insights into B-cell differentiation.
    Manis J; Schwartz RS
    N Engl J Med; 1996 Nov; 335(20):1523-5. PubMed ID: 8890105
    [No Abstract]   [Full Text] [Related]  

  • 3. [X-linked agammaglobulinemia].
    Kanegane H; Miyawaki T
    Ryoikibetsu Shokogun Shirizu; 2000; (32):59-62. PubMed ID: 11212813
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutations in the mu heavy-chain gene in patients with agammaglobulinemia.
    Yel L; Minegishi Y; Coustan-Smith E; Buckley RH; Trübel H; Pachman LM; Kitchingman GR; Campana D; Rohrer J; Conley ME
    N Engl J Med; 1996 Nov; 335(20):1486-93. PubMed ID: 8890099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autosomal recessive agammaglobulinemia].
    Kanegane H; Miyawaki T
    Ryoikibetsu Shokogun Shirizu; 2000; (32):63-5. PubMed ID: 11212824
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic basis of abnormal B cell development.
    Conley ME; Cooper MD
    Curr Opin Immunol; 1998 Aug; 10(4):399-406. PubMed ID: 9722915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of the pre-BCR complex in a large cohort of patients affected by autosomal-recessive agammaglobulinemia.
    Ferrari S; Zuntini R; Lougaris V; Soresina A; Sourková V; Fiorini M; Martino S; Rossi P; Pietrogrande MC; Martire B; Spadaro G; Cardinale F; Cossu F; Pierani P; Quinti I; Rossi C; Plebani A
    Genes Immun; 2007 Jun; 8(4):325-33. PubMed ID: 17410177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell-deficient muMT mice as an experimental model for Mycoplasma infections in X-linked agammaglobulinemia.
    Berglöf A; Sandstedt K; Feinstein R; Bölske G; Smith CI
    Eur J Immunol; 1997 Aug; 27(8):2118-21. PubMed ID: 9295053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages.
    de Weers M; Verschuren MC; Kraakman ME; Mensink RG; Schuurman RK; van Dongen JJ; Hendriks RW
    Eur J Immunol; 1993 Dec; 23(12):3109-14. PubMed ID: 8258324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. xid affects events leading to B cell cycle entry.
    Brorson K; Brunswick M; Ezhevsky S; Wei DG; Berg R; Scott D; Stein KE
    J Immunol; 1997 Jul; 159(1):135-43. PubMed ID: 9200448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BTK mutations in patients with X-linked agammaglobulinemia: lack of correlation between presence of peripheral B lymphocytes and specific mutations.
    Tao L; Boyd M; Gonye G; Malone B; Schwaber J
    Hum Mutat; 2000 Dec; 16(6):528-9. PubMed ID: 11102984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Bruton's tyrosine kinase in B-cell development and function: a genetic perspective.
    Satterthwaite AB; Witte ON
    Immunol Rev; 2000 Jun; 175():120-7. PubMed ID: 10933597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B lymphocytes from X-linked agammaglobulinemia. Delayed expression of light chain and demonstration of Lyonization in carriers.
    Schwaber J; Payne J; Chen R
    J Clin Invest; 1988 Feb; 81(2):514-22. PubMed ID: 3123521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human genetics. Becoming B cells.
    Desiderio S
    Nature; 1993 Jan; 361(6409):202-3. PubMed ID: 7678697
    [No Abstract]   [Full Text] [Related]  

  • 15. Functional analysis of peripheral blood B cells in patients with X-linked agammaglobulinemia.
    Nonoyama S; Tsukada S; Yamadori T; Miyawaki T; Jin YZ; Watanabe C; Morio T; Yata J; Ochs HD
    J Immunol; 1998 Oct; 161(8):3925-9. PubMed ID: 9780159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage.
    Hendriks RW; de Bruijn MF; Maas A; Dingjan GM; Karis A; Grosveld F
    EMBO J; 1996 Sep; 15(18):4862-72. PubMed ID: 8890160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analysis of patients with defects in early B-cell development.
    Conley ME; Broides A; Hernandez-Trujillo V; Howard V; Kanegane H; Miyawaki T; Shurtleff SA
    Immunol Rev; 2005 Feb; 203():216-34. PubMed ID: 15661032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predominance of sterile immunoglobulin transcripts in a female phenotypically resembling Bruton's agammaglobulinemia.
    de la Morena M; Haire RN; Ohta Y; Nelson RP; Litman RT; Day NK; Good RA; Litman GW
    Eur J Immunol; 1995 Mar; 25(3):809-15. PubMed ID: 7705412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype/phenotype correlations in X-linked agammaglobulinemia.
    Broides A; Yang W; Conley ME
    Clin Immunol; 2006; 118(2-3):195-200. PubMed ID: 16297664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autosomal recessive agammaglobulinemia due to defect in μ heavy chain caused by a novel mutation in the IGHM gene.
    Silva P; Justicia A; Regueiro A; Fariña S; Couselo JM; Loidi L
    Genes Immun; 2017 Sep; 18(3):197-199. PubMed ID: 28769069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.